Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Description complète

Détails bibliographiques

Auteurs principaux:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2020-11-01
Collection:	Molecular Oncology
Sujets:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
Accès en ligne:	https://doi.org/10.1002/1878-0261.12790
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!